BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21915857)

  • 21. C. elegans: a model of Fanconi anemia and ICL repair.
    Youds JL; Barber LJ; Boulton SJ
    Mutat Res; 2009 Jul; 668(1-2):103-16. PubMed ID: 19059419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
    Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
    Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel frame-shift deletion in FANCF gene causing autosomal recessive Fanconi anemia: a case report.
    Zareifar S; Dastsooz H; Shahriari M; Faghihi MA; Shekarkhar G; Bordbar M; Zekavat OR; Shakibazad N
    BMC Med Genet; 2019 Jul; 20(1):122. PubMed ID: 31288759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer.
    Tokunaga E; Okada S; Kitao H; Shiotani S; Saeki H; Endo K; Morita M; Kakeji Y; Maehara Y
    Breast Cancer; 2011 Apr; 18(2):120-3. PubMed ID: 19813073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic variability in patients with Fanconi anemia and biallelic FANCF mutations.
    Tryon R; Zierhut H; MacMillan ML; Wagner JE
    Am J Med Genet A; 2017 Jan; 173(1):260-263. PubMed ID: 27714961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Granulosa cell tumorigenesis in genetically hypogonadal-immunodeficient mice grafted with ovaries from tumor-susceptible donors.
    Beamer WG; Shultz KL; Tennent BJ; Shultz LD
    Cancer Res; 1993 Aug; 53(16):3741-6. PubMed ID: 8339285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fanconi anaemia genes and susceptibility to cancer.
    Mathew CG
    Oncogene; 2006 Sep; 25(43):5875-84. PubMed ID: 16998502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer.
    Pejovic T; Yates JE; Liu HY; Hays LE; Akkari Y; Torimaru Y; Keeble W; Rathbun RK; Rodgers WH; Bale AE; Ameziane N; Zwaan CM; Errami A; Thuillier P; Cappuccini F; Olson SB; Cain JM; Bagby GC
    Cancer Res; 2006 Sep; 66(18):9017-25. PubMed ID: 16982743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural determinants of human FANCF protein that function in the assembly of a DNA damage signaling complex.
    Kowal P; Gurtan AM; Stuckert P; D'Andrea AD; Ellenberger T
    J Biol Chem; 2007 Jan; 282(3):2047-55. PubMed ID: 17082180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interferon consensus sequence binding protein (ICSBP/IRF8) activates transcription of the FANCF gene during myeloid differentiation.
    Saberwal G; Horvath E; Hu L; Zhu C; Hjort E; Eklund EA
    J Biol Chem; 2009 Nov; 284(48):33242-54. PubMed ID: 19801548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells.
    Zhao L; Li N; Yu JK; Tang HT; Li YL; He M; Yu ZJ; Bai XF; Zheng ZH; Wang EH; Wei MJ
    Braz J Med Biol Res; 2014 Jan; 47(1):24-34. PubMed ID: 24345874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer.
    Narayan G; Arias-Pulido H; Nandula SV; Basso K; Sugirtharaj DD; Vargas H; Mansukhani M; Villella J; Meyer L; Schneider A; Gissmann L; Dürst M; Pothuri B; Murty VV
    Cancer Res; 2004 May; 64(9):2994-7. PubMed ID: 15126331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Fanconi anemia gene product FANCF is a flexible adaptor protein.
    Léveillé F; Blom E; Medhurst AL; Bier P; Laghmani el H; Johnson M; Rooimans MA; Sobeck A; Waisfisz Q; Arwert F; Patel KJ; Hoatlin ME; Joenje H; de Winter JP
    J Biol Chem; 2004 Sep; 279(38):39421-30. PubMed ID: 15262960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FANCF methylation contributes to chemoselectivity in ovarian cancer.
    Olopade OI; Wei M
    Cancer Cell; 2003 May; 3(5):417-20. PubMed ID: 12781358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing of fanconi anemia complementation group f exhibits potent chemosensitization of mitomycin C activity in breast cancer cells.
    Yu J; Zhao L; Li Y; Li N; He M; Bai X; Yu Z; Zheng Z; Mi X; Wang E; Wei M
    J Breast Cancer; 2013 Sep; 16(3):291-9. PubMed ID: 24155758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FANCF hypomethylation is associated with colorectal cancer in Han Chinese.
    Yu H; Pan R; Gao T; Wu D; Ying J; Duan S
    Turk J Gastroenterol; 2020 Aug; 31(8):558-565. PubMed ID: 32915143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantability of induced granulosa cell tumors and of luteoma in mice; secondary effects of these growths.
    FURTH J
    Proc Soc Exp Biol Med; 1946 Mar; 61():212-4. PubMed ID: 21024146
    [No Abstract]   [Full Text] [Related]  

  • 38. Incidence of tubulostromal adenoma of the ovary in aged germ cell-deficient mice.
    Duncan MK; Chada KK
    J Comp Pathol; 1993 Jul; 109(1):13-9. PubMed ID: 8408777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantable luteoma in mice and associated secondary changes.
    FURTH J; SOBEL H
    Cancer Res; 1947 Apr; 7(4):246-62. PubMed ID: 20266461
    [No Abstract]   [Full Text] [Related]  

  • 40. The Validation of a Precursor Lesion of Epithelial Ovarian Cancer in
    Sczelecki S; Pitman JL
    Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.